Kevin O’Boyle

715 total citations
29 papers, 539 citations indexed

About

Kevin O’Boyle is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kevin O’Boyle has authored 29 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kevin O’Boyle's work include Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glycosylation and Glycoproteins Research (7 papers). Kevin O’Boyle is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glycosylation and Glycoproteins Research (7 papers). Kevin O’Boyle collaborates with scholars based in United States. Kevin O’Boyle's co-authors include Peter H. Wiernik, Doru T Alexandrescu, Janice P. Dutcher, Kenneth O. Lloyd, Michael B. Atkins, Jeffrey A. Sosman, Janice Dutcher, Kim Margolin, Stanley J. Oiseth and Nancy Kemeny and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The American Journal of Medicine.

In The Last Decade

Kevin O’Boyle

27 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin O’Boyle United States 13 239 233 186 85 73 29 539
A. Bodurtha Canada 15 376 1.6× 256 1.1× 222 1.2× 173 2.0× 78 1.1× 23 763
Yvette van Hensbergen Netherlands 12 348 1.5× 129 0.6× 301 1.6× 47 0.6× 57 0.8× 22 666
Adel L. Barsoum United States 14 203 0.8× 448 1.9× 271 1.5× 108 1.3× 35 0.5× 37 674
Gerd Leder Germany 11 287 1.2× 93 0.4× 212 1.1× 22 0.3× 55 0.8× 13 526
Yusuke Makiguchi Japan 9 118 0.5× 232 1.0× 304 1.6× 157 1.8× 30 0.4× 26 556
Rekha Samuel United States 9 261 1.1× 196 0.8× 280 1.5× 19 0.2× 67 0.9× 9 706
Jürgen Wolf Germany 12 275 1.2× 137 0.6× 208 1.1× 67 0.8× 202 2.8× 25 605
Antonio Cusmai Italy 11 292 1.2× 138 0.6× 197 1.1× 30 0.4× 124 1.7× 28 577
Audrey Bouillez United States 14 375 1.6× 262 1.1× 640 3.4× 84 1.0× 105 1.4× 16 931
Nana Tchabo United States 14 235 1.0× 107 0.5× 326 1.8× 23 0.3× 59 0.8× 25 744

Countries citing papers authored by Kevin O’Boyle

Since Specialization
Citations

This map shows the geographic impact of Kevin O’Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin O’Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin O’Boyle more than expected).

Fields of papers citing papers by Kevin O’Boyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin O’Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin O’Boyle. The network helps show where Kevin O’Boyle may publish in the future.

Co-authorship network of co-authors of Kevin O’Boyle

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin O’Boyle. A scholar is included among the top collaborators of Kevin O’Boyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin O’Boyle. Kevin O’Boyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sosman, Jeffrey A., Walter J. Urba, Lawrence E. Flaherty, et al.. (2008). Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma. Journal of Clinical Oncology. 26(14). 2292–2298. 72 indexed citations
2.
Alexandrescu, Doru T, et al.. (2005). Metastatic Solid-pseudopapillary Tumour of the Pancreas: Clinico-biological Correlates and Management. Clinical Oncology. 17(5). 358–363. 43 indexed citations
3.
Koulova, Lydia, et al.. (2004). Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): Report of three cases. American Journal of Hematology. 78(1). 49–54. 36 indexed citations
4.
Alexandrescu, Doru T, et al.. (2004). Fatal Intra-Alveolar Hemorrhage After Rituximab in a Patient with non-Hodgkin Lymphoma. Leukemia & lymphoma. 45(11). 2321–2325. 51 indexed citations
5.
6.
Dutcher, Janice P., et al.. (2000). 20th‐Century Advances in Drug Therapy in Oncology—Part I. The Journal of Clinical Pharmacology. 40(9). 1007–1024. 22 indexed citations
7.
Goldstein, Julia, et al.. (1999). ICAM-1 co-stimulation has differential effects on the activation of CD4+ and CD8+ T cells. European Journal of Immunology. 29(3). 809–814. 26 indexed citations
8.
Goldstein, Julia, et al.. (1999). ICAM-1 co-stimulation has differential effects on the activation of CD4+ and CD8+ T cells. European Journal of Immunology. 29(3). 809–814. 1 indexed citations
9.
10.
O’Boyle, Kevin, Edward L. Schwartz, Avi I. Einzig, et al.. (1997). Development of two radioimmunoassays to detect paclitaxel in sera and in cerebrospinal, ascitic, and pleural fluids. Cancer. 79(5). 1022–1030. 8 indexed citations
11.
O’Boyle, Kevin, et al.. (1996). Specificity Analysis of Murine Monoclonal Antibodies Reactive with Tn, Sialylated Tn, T, and Monosialylated (2 → 6) T Antigens. Hybridoma. 15(6). 401–408. 22 indexed citations
12.
O’Boyle, Kevin, et al.. (1996). Patterns of Ganglioside Expression in B Cell Neoplasms. Leukemia & lymphoma. 21(3-4). 255–266. 11 indexed citations
13.
14.
Oleksowicz, Leslie, et al.. (1994). Interleukins in Cancer Therapy. Clinical Immunotherapeutics. 1(4). 271–281. 4 indexed citations
15.
O’Boyle, Kevin & Kathryn Wright. (1994). Anti-Tn human monoclonal antibodies generated following active immunization with partially desialylated ovine submaxillary mucin. Human Antibodies. 5(1-2). 25–31. 7 indexed citations
16.
Sosman, Jeffrey A., Geoffrey R. Weiss, Kim Margolin, et al.. (1993). Phase IB clinical trial of anti-CD3 followed by high-dose bolus interleukin-2 in patients with metastatic melanoma and advanced renal cell carcinoma: clinical and immunologic effects.. Journal of Clinical Oncology. 11(8). 1496–1505. 31 indexed citations
17.
Fischl, Margaret A., Susan E. Krown, Kevin O’Boyle, et al.. (1993). Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.. PubMed. 6(3). 259–64. 42 indexed citations
18.
Sparano, Joseph A. & Kevin O’Boyle. (1992). The potential role for biological therapy in the treatment of breast cancer.. PubMed. 19(3). 333–41. 7 indexed citations
19.
O’Boyle, Kevin & Nancy Kemeny. (1989). Synchronous colon and renal cancers: Six cases of a clinical entity. The American Journal of Medicine. 87. 691–693. 2 indexed citations
20.
O’Boyle, Kevin & Nancy E. Kemeny. (1989). Synchronous colon and renal cancers: Six cases of a clinical entity. The American Journal of Medicine. 87(6). 691–693. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Bodurtha Breakdown of academic impact, for papers by Yvette van Hensbergen Breakdown of academic impact, for papers by Adel L. Barsoum Breakdown of academic impact, for papers by Gerd Leder Breakdown of academic impact, for papers by Yusuke Makiguchi Breakdown of academic impact, for papers by Rekha Samuel Breakdown of academic impact, for papers by Jürgen Wolf Breakdown of academic impact, for papers by Antonio Cusmai Breakdown of academic impact, for papers by Audrey Bouillez Breakdown of academic impact, for papers by Nana Tchabo
Rankless by CCL
2026